Skip to main content
. 2015 Feb 4;2:14056. doi: 10.1038/mtm.2014.56

Table 2. List of used cell lines and corresponding growth media.

Cell line Medium
B16, GL26, HEK293E, HeLa DMEM with stable glutamine and Na pyruvate (PAA, GE Healthcare), 10% FBS (PAA, GE Healthcare), 1% Penicillin/Streptomycin (Gibco)
C2C12 DMEM with stable glutamine and Na pyruvate, 15% FBS, 1% Penicillin/Streptomycin
MCF7 DMEM with stable glutamine and Na pyruvate, 10% FBS, 1% Penicillin/Streptomycin, 10 µg/ml insulin (Sigma), 0.1 mmol/l nonessential amino acids (Gibco)
MCF10-2A F12 DMEM with stable glutamine and Na pyruvate (Gibco), 10% FBS, 10 µg/ml insulin, 0.5 µg/ml hydrocortisone (Gibco), 100 ng/ml cholera toxin (Sigma), 20 ng/ml epidermal growth factor (Sigma) and 1% Penicillin/Streptomycin
HCT116 p53+/+ and HCT116 p53−/− McCoy’s with stable glutamine (PAA, GE Healthcare), 10% FBS, 1% Penicillin/Streptomycin (supplemented with 50 µg/ml G418 (Gibco) for p53−/− cells)
Saos-2 McCoy’s with stable glutamine, 15% FBS, 1% Penicillin/Streptomycin
LN-229, T98G, U87, Colo857 RPMI-glutamax (Gibco), 10% FBS, 1% Penicillin/Streptomycin
Raji RPMI-glutamax, 10% FBS, 1 mmol/l Na pyruvate (Gibco), 0.1 mmol/l nonessential aminoacids, 10 µg/ml gentamicin (Gibco)
BJ DMEM with stable glutamine and Na pyruvate, 10% FBS, 0.1 mmol/l nonessential aminoacids